Day: September 5, 2024

MIAMI, Sept. 05, 2024 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announced that it was awarded conditional approval to serve as a pharmaceutical processor by the Virginia Cannabis Control Authority (“CCA”) for Virginia’s Health Service Area 1 (“HSA 1”). HSA 1 encompasses various cities and counties in Virginia, including Charlottesville, Fredericksburg, Spotsylvania, and Stafford. “We’re proud to have earned the opportunity to serve patients in Virginia, particularly in a region of ~1.5 million people that has lacked access to medical cannabis for some time,” said David Goubert, President & CEO of AYR. “This is an exciting moment for AYR, reflective of our continued efforts towards building our business...

REDMOND, Wash., Sept. 05, 2024 (GLOBE NEWSWIRE) — Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a leader in AI-driven video, sensor, and data management surveillance solutions, announced the closing of its previously announced public offering with net proceeds to the Company of approximately $7.04 million, after deducting placement agent fees and offering expenses. The offering consisted of 2,882,883 shares of its common stock and warrants to purchase up to an aggregate of 2,882,883 shares of its common stock at a combined public offering price $2.775 per share and associated common warrant in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock was sold together with one warrant to purchase one share of common stock. The warrants have an exercise price of...

Key PointsImmuron completes pre-IND meeting with FDA on the development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) Previous clinical trial data on IMM-529 provides support for continued development of IMM-529 Investigational new drug (IND) application for IMM-529 planned for 1H 2025MELBOURNE, Australia, Sept. 05, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce that it has received favourable feedback from the United States Food and Drug Administration (FDA) on the pre-IND (investigational new drug) information package to support the clinical development of IMM-529. Following the FDA’s guidance and feedback, the Company now plans to file an investigational new drug...

COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at 31 August 2024 Paris, 05 September 2024 – 17.45Total Number of Shares Capital Theoretical Number of Voting Rights1 Number of Real Voting Rights2150,179,792 150,179,792 149,384,361(1)   including own shares(2)   excluding own shares Regulated documents posted by COFACE SA have been secured and authenticated with the blockchain technology by Wiztrust. You can check the authenticity on the website www.wiztrust.com.  About Coface   COFACE SA is a société anonyme (joint-stock corporation), with a Board of Directors (Conseil d’Administration) incorporated under the laws of France, and is governed by the provisions of the French Commercial Code. The Company is registered with the Nanterre Trade and Companies...

Disclosure Of Trading In Own SharesFor August 2024 CLICHY – 05 SEP 2024 In compliance with general regulation on share buy-backs, SOCIÉTÉ BIC declares below the transactions made on its own shares for August 2024:Date Number of shares Average weighted price in € Amount in €05/08/2024 2,459 56.4552 138,823.3406/08/2024 2,741 57.3061 157,076.0207/08/2024 6,000 57.7000 346,200.0008/08/2024 921 57.9151 53,339.8109/08/2024 14,443 58.3000 842,026.9009/08/2024 5,223 57.9850 302,855.6612/08/2024 36,083 58.0000 2,092,814.0012/08/2024 5,500 56.8000 312,400.0028/08/2024 4,752 60.3804 286,927.6629/08/2024 754 60.4755 45,598.5330/08/2024 1,955 60.9918 119,238.97TOTAL 80,831 58.1126 4,697,300.88ABOUT BIC A...

Strasbourg, France, September 5, 2024, 5 : 45 PM CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that its management will participate in the following upcoming investor meetings taking place in Paris, France:6th HealthTech Innovation Days (HTID), September 17 & 18, 2024 Investor Access Forum, October 15 & 16, 2024*** About Transgene Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines and oncolytic viruses: TG4050, the first individualized...

TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) — Montero Mining and Exploration Ltd. (TSX-V: MON) is pleased to announce the appointment of Timothy (Tim) Livesey as a Non-Executive Director to Montero’s Board of Directors, effective as of September 5, 2024. Tim Livesey is a seasoned geologist and mining professional with over 30 years of experience in gold and base metal exploration, working on a number of exploration and advanced stage projects through feasibility to development. He also brings expertise in international investment disputes and arbitration. Tim’s career spans 14 years at Barrick Gold, where he held various global roles. He was instrumental in the development of the Tethyan Copper Company Joint Venture at Reko Diq copper-gold project in Pakistan, a project that later became involved in an ICSID arbitration process. Tim...

Sanoma Corporation, Stock Exchange Release, 5 September 2024 at 17:55 EET Sanoma issues a EUR 150 million social bond NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NOTES OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Sanoma Corporation (“Sanoma”) issues senior unsecured social notes of EUR 150 million (the “Notes”). The maturity of the Notes is three years and they mature on 13 September 2027. The Notes carry fixed annual interest of 4.000 percent. The issue price of the notes is 99.872 percent. The offering was allocated to over 40 investors. “Sanoma Learning’s products and services enable and support teachers and...